Skip to content
zameds

Mycophenolate mofetil (Mylate, Myfenotil)

Mycophenolate mofetil

Trinity Pharma (Pty) Ltd

S4Read from the PI-PIL document and verified

Registration

Applicant
Trinity Pharma (Pty) Ltd
Certificate holder
Trinity Pharma (Pty) Ltd
Registrations
4
Schedule source
SAHPRA documentation

Variants

ProductStrength and formRegistrationStatusScheduleLeaflets
Mylate 250

EACH CAPSULE CONTAINS: MYCOPHENOLATE MOFETIL 250,0 mg

250 mgCapsule59013159/32.16/0131Approved 23 June 2026RegisteredS4PIPIL
Myfenotil 250

EACH CAPSULE CONTAINS: MYCOPHENOLATE MOFETIL 250,0 mg

250 mgCapsule590132.13159/32.16/0132.131Approved 23 June 2026RegisteredS4PIPIL
Mylate 500

EACH TABLET CONTAINS: MYCOPHENOLATE MOFETIL 500,0 mg

50059019959/32.16/0199RegisteredNot determinedNone
Myfenotil 500

EACH TABLET CONTAINS: MYCOPHENOLATE MOFETIL 500,0 mg

500590200.19959/32.16/0200.199RegisteredNot determinedNone

Regulatory status

Where S4 sits on the scale

Prescription-only medicine.

Schedule 4 covers most ordinary prescription medicines. You need a prescription from an authorised prescriber, such as a doctor or dentist, and a pharmacist dispenses it. Its price, name, pack size and strength can still be told to the public, as long as nothing links it to what it treats.

Schedule S4, read from the product's PI-PIL leaflet.

Who may supply: A pharmacist dispensing against a written or verbal prescription from an authorised prescriber; a veterinarian, who may also prescribe, compound or dispense it directly; a medical practitioner or dentist, who may prescribe it and may compound or dispense it directly only if licensed under section 22C(1)(a); manufacturers and wholesalers may supply people who may lawfully possess it; and, for animal treatment, a person practising a para-veterinary profession, on a veterinarian's written or verbal instruction.

This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.

C23H31NO7433.50 g/mol

2-Morpholin-4-ylethyl (E)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1H-2-benzofuran-5-yl)-4-methylhex-4-enoate

Drag to rotate. Structure from PubChem CID 5281078.

SAHPRA documents

Schedule verified from official documents

Schedule Verification

This medication's schedule (S4) has been verified from official SAHPRA documents with 90% confidence.

These documents are provided by SAHPRA for informational purposes. Always consult with a healthcare professional for medical advice.

Background

Loading...
Loading Wikipedia summary

Research articles

Loading...
Loading PubMed articles